Swixx Biopharma

Switzerland
Baar, Zug, Switzerland

Company profile

Swixx Biopharma company profile

Swixx Biopharma fully represents biopharma companies in the CEE. It is designed to fully replace biopharma, OTC, and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE, that the multinational chooses not to enter, or to exit. The company was founded in 2014 and is registered in Baar, Switzerland. It has 100%-owned affiliates in Albania, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Kosovo, Latvia, Lithuania, North Macedonia, Montenegro, Poland, Romania, Russia, Serbia, Slovakia, and Slovenia.

Business identity

Contact email
[email protected]
Phone number
+41 41 5523 440
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Revenue range
$100M-$1B
Founded
2014-12-01, Month

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
6
Total equity funding
$55M
Last funding
Debt Financing / 2025-12-15
Last equity funding
Series Unknown
Investors
6
Lead investors
2
Founders
3
Articles
29
Exited on
2025-12-15

Founders and investors

Founders

Michael SeeleyPetr NemecStuart Swanson

Lead investors

Ares ManagementMérieux Equity Partners

Investors

Ares ManagementCitiCredit SuisseMérieux Equity PartnersUBS